Mediso acquires nuclear medicine supplier Bartec Technologies
FARNBOROUGH, England, and BUDAPEST, Hungary, May 5, 2022 /PRNewswire/ -- Mediso Ltd today announced the acquisition of Bartec Technologies Ltd, UK based company specialised in the supply, installation and support of Nuclear Medicine and Molecular Imaging equipment and accessories. The acquisition strengthens Mediso's market position in the UK and Ireland. Financial details...
ONE DRUG FOR ONE BUG: DEBIOPHARM TO DISCUSS THE POTENTIAL OF PATHOGEN-SPECIFIC ANTIBIOTICS AT THE 2022 WORLD AMR CONGRESS
International health authorities, such as the WHO and the CDC are warning of the emerging danger of bacterial infections resistant to current antibiotics The 2022 World Anti-Microbial Resistance (AMR) Congress in the greater Washington D.C. area is serving as a forum to openly address the threat of AMR Debiopharm will join the action-focused discussions around this silent...
Microban International Appoints Shermon McMillan as New President
HUNTERSVILLE, N.C., Oct. 16, 2025 /PRNewswire/ -- Microban International, the global leader in antimicrobial and odor control solutions, today announced the appointment of Shermon McMillan as its new president. A seasoned global executive with a proven record of driving growth at Fortune 500 companies, McMillan will guide Microban strategy, operations and innovation...
TraceLink Named to Inbound Logistics Top 100, Preparing Healthcare and Life Sciences Companies for Agentic Operations Across Its Global Supply Network
Recognition highlights TraceLink's role in linking trading partners on a shared, real-time information network to enable coordinated logistics operations at global scale Summary TraceLink has been named one of the Top 100 Logistics & Supply Chain Technology Providers for 2026 by Inbound Logistics, recognizing its role in linking supply chain partners...
NeuroAiD(TM)II holds promise as a safe add-on therapy to standard Alzheimer Disease symptomatic treatments and may have a disease modifying effect by delaying disease progression
SINGAPORE, Jan. 13, 2022 /PRNewswire/ -- Moleac is pleased to announce the release of the ATHENE study results, published in the Journal of the American Medical Director Association (JAMDA)1. Alzheimer's Disease (AD) and other dementias cause a heavy economic and public healthcare burden worldwide. The number of people living with dementia continues to increase mainly due to population...
United Imaging Healthcare Releases 2024 ESG Report, Driving Sustainable Development Through Innovation
SHANGHAI, April 29, 2025 /PRNewswire/ -- United Imaging Healthcare (SSE: 688271) has released its 2024 Environmental, Social, and Governance (ESG) Report, reaffirming its mission to bring Equal Healthcare for All. The report outlines continued progress in sustainability, compliance, and corporate responsibility, emphasizing how the company integrates long-term social value with global business growth. In 2024, the company achieved...
1,000+ Medical Device Manufacturing Leaders Gather at Medtec 2024
Experts Deliver Key Insights into Industry Trends SHANGHAI, Aug. 1, 2024 /PRNewswire/ -- The Government Work Report releases in early 2024 emphasized the need to "explore new avenues in life sciences." As a key area for developing new productivity, the medical device industry encompasses both the emerging high-end manufacturing sector and the future-focused healthcare sector. Medtec, a major exhibition for...
SMARTKEM, INC. APPOINTS MELISA A. DENIS TO THE BOARD OF DIRECTORS
MANCHESTER, England, Nov. 28, 2023 /PRNewswire/ -- SmartKem, Inc. (OTCQB: SMTK), a company seeking to reshape the world of electronics with its disruptive organic thin-film transistors (OTFTs) that have the potential to drive the next generation of displays, today announced the appointment of Melisa A. Denis to the SmartKem Board of Directors, effective November 21, 2023. Ms. Denis...
Alphamab Oncology Collaborated with ArriVent in relation to the Research, Development and Commercialization of ADC Products
SUZHOU, China, June 6, 2024 /PRNewswire/ -- Alphamab Oncology (stock code: 9966.HK) announced that Jiangsu Alphamab Biopharmaceuticals Co., Ltd. ("Alphamab"), a wholly-owned subsidiary of the Company, entered into a research and collaboration agreement (the "Collaboration Agreement") with ArriVent BioPharma, Inc., the shares of which are listed on the Nasdaq Global Market (ticker symbol: AVBP) ("ArriVent"), pursuant to which, Alphamab...
Olverembatinib Surmounts Ponatinib and Asciminib Resistance and Is Well Tolerated in Patients With CML and Ph+ ALL: New Report in JAMA Oncology
ROCKVILLE, Md. and SUZHOU, China, Nov. 22, 2024 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in discovering, developing and commercializing therapies to address global unmet medical needs primarily for malignancies, announced today that findings from a phase Ib multicenter clinical trial (NCT04260022) of its third-generation BCR-ABL1 tyrosine kinase inhibitor...
